CONDUCTION DISORDER side effect
What is CONDUCTION DISORDER ?Drugs associated with CONDUCTION DISORDER
ATACAND ATAZANAVIR ATENOLOL CIBENZOLINE DICLOFENAC ESCITALOPRAM FABRAZYME FLUCONAZOLE HERCEPTIN LASILIX LASIX MORPHINE REMINYL SYMBICORT VINORELBINE ZELNORM ZYPREXACONDUCTION DISORDER : Symbicort Side Effects Report #5647408-4
Health Professional from FRANCE reported SYMBICORT problem on Feb 25, 2008. Female patient was diagnosed with asthma, rheumatoid arthritis and was treated with SYMBICORT. After drug was administered, patient experienced the following problems/side effects: conduction disorder, . SYMBICORT dosage: unknown. During the same period patient was treated with FELODIPINE, FLECAINIDE ACETATE, PAROXETINE. Patient was hospitalized. Patient recovered.
CONDUCTION DISORDER : Zyprexa Side Effects Report #5613550-7
ZYPREXA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 25, 2008. Male patient, 28 years of age, was diagnosed with bipolar i disorder and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: conduction disorder, confusional state, delusion, hyperhidrosis, left atrial dilatation, overdose, sinus arrhythmia, weight increased, . ZYPREXA dosage: 20 MG, UNK. During the same period patient was treated with THORAZINE, ATIVAN, RISPERIDONE, ANTIPSYCHOTICS. Patient recovered.
CONDUCTION DISORDER : Herceptin Side Effects Report #5607772-9
Physician from UNITED KINGDOM reported HERCEPTIN problem on Jan 17, 2008. Female patient, 60 years of age, was diagnosed with breast cancer and was treated with HERCEPTIN. After drug was administered, patient experienced the following problems/side effects: conduction disorder, ventricular arrhythmia, ventricular extrasystoles, . HERCEPTIN dosage: unknown. During the same period patient was treated with ANTHRACYCLINE, ENALAPRIL, TAMOXIFEN. Patient recovered.
CONDUCTION DISORDER : Vinorelbine Side Effects Report #5468916-5
VINORELBINE TARTRATE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 17, 2007. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with VINORELBINE TARTRATE. After drug was administered, patient experienced the following problems/side effects: conduction disorder, dyspnoea, renal failure, respiratory failure, . VINORELBINE TARTRATE dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient died.
CONDUCTION DISORDER : Fluconazole Side Effects Report #5420588-1
Consumer or non-health professional from FRANCE reported FLUCONAZOLE problem on July 20, 2007. Male patient, 32 years of age, was diagnosed with oesophageal candidiasis, depressive symptom, hiv infection and was treated with FLUCONAZOLE. After drug was administered, patient experienced the following problems/side effects: conduction disorder, constipation, dysuria, electrocardiogram abnormal, electrocardiogram pr prolongation, orthostatic hypotension, polydipsia, . FLUCONAZOLE dosage: 200 MG (200 MG, 1 IN 1 D). During the same period patient was treated with MAPROTILINE, RITONAVIR, SAQUINAVIR, INDINIVIR SULPHATE, STAVUDINE, AMPRENAVIR, SULFAMETHOXAZOLE, VALPROIC ACID. Patient recovered.
CONDUCTION DISORDER : Zyprexa Side Effects Report #5646364-2
ZYPREXA problem was reported by a Physician from UNITED STATES on Feb 25, 2008. Male patient, 28 years of age, was diagnosed with bipolar i disorder and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: alcohol withdrawal syndrome, conduction disorder, confusional state, convulsion, delusion, hyperhidrosis, left atrial dilatation, overdose, sinus arrhythmia, . ZYPREXA dosage: 20 MG, UNK. During the same period patient was treated with THORAZINE, ATIVAN, RISPERIDONE, ANTIPSYCHOTICS. Patient recovered.
CONDUCTION DISORDER : Lasilix Side Effects Report #5610900-2
Consumer or non-health professional from reported LASILIX problem on Jan 23, 2008. Male patient, 81 years of age, was treated with LASILIX. After drug was administered, patient experienced the following problems/side effects: bradycardia, conduction disorder, hyperkalaemia, hyponatraemia, . LASILIX dosage: unknown. During the same period patient was treated with ATACAND, ARANESP, TARDYFERON, IMOVANE, SYMBICORT, NITRODERM, LANTUS. Patient was hospitalized. Patient recovered.
CONDUCTION DISORDER : Atazanavir Side Effects Report #5594560-5
ATAZANAVIR SULPHATE problem was reported by a Health Professional from UNITED STATES on Jan 14, 2008. Male patient, 13 years of age, weighting 97.00 lb, was diagnosed with hiv infection and was treated with ATAZANAVIR SULPHATE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, conduction disorder, gamma-glutamyltransferase increased, hyperbilirubinaemia, incorrect dose administered, left atrial dilatation, . ATAZANAVIR SULPHATE dosage: unknown. During the same period patient was treated with ATAZANAVIR SULPHATE, VIDEX EC, ZERIT, ALBUTEROL, PHENERGAN W. Patient was hospitalized. Patient recovered.
CONDUCTION DISORDER : Reminyl Side Effects Report #5604724-X
Physician from SWITZERLAND reported REMINYL problem on Jan 17, 2008. Male patient, 79 years of age, was treated with REMINYL. After drug was administered, patient experienced the following problems/side effects: bundle branch block left, conduction disorder, dementia, sinus bradycardia, . REMINYL dosage: unknown. During the same period patient was treated with RISPERDAL, ASPIRIN, SERETIDE, SPIRIVA. Patient was hospitalized. Patient recovered.
CONDUCTION DISORDER : Cibenzoline Side Effects Report #5537076-4
CIBENZOLINE problem was reported by a Health Professional from UNITED STATES on Dec 06, 2007. Male patient, 65 years of age, was diagnosed with ventricular extrasystoles and was treated with CIBENZOLINE. After drug was administered, patient experienced the following problems/side effects: cardiogenic shock, conduction disorder, hyperkalaemia, liver disorder, nausea, renal failure, vomiting, . CIBENZOLINE dosage: CIBENZOLINE (ORAL)380MG/DAY THEN 6MG/KG/DAY. During the same period patient was treated with CAPTOPRIL, FUROSEMIDE, GLIBENCLAMIDE. Patient was hospitalized. Patient recovered.
CONDUCTION DISORDER : Escitalopram Side Effects Report #5562850-8
Consumer or non-health professional from UNITED STATES reported ESCITALOPRAM problem on Dec 12, 2007. Male patient, 67 years of age, weighting 142.2 lb, was treated with ESCITALOPRAM. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, conduction disorder, mitral valve incompetence, nausea, non-cardiac chest pain, pulmonary valve incompetence, qrs axis abnormal, sinus arrhythmia, tricuspid valve incompetence, . ESCITALOPRAM dosage: 10 MG OD - ORAL. During the same period patient was treated with METOCLOPRAMIDE, LEVOTHYROXINE, SAW PALMETTO, ACETYLSALICYLIC ACID SRT, NIACIN, FISH OIL, GINKGO BILOBA. Patient was hospitalized. Patient recovered.
CONDUCTION DISORDER : Lasix Side Effects Report #5512783-8
LASIX problem was reported by a Consumer or non-health professional from on Nov 05, 2007. Male patient, 81 years of age, was treated with LASIX. After drug was administered, patient experienced the following problems/side effects: bradycardia, conduction disorder, hyperkalaemia, . LASIX dosage: unknown. During the same period patient was treated with ATACAND, ARANESP, TARDYFERON, IMOVANE, SYMBICORT, NITRODERM, LANTUS. Patient was hospitalized. Patient recovered.
CONDUCTION DISORDER : Atacand Side Effects Report #5514631-9
Health Professional from FRANCE reported ATACAND problem on Nov 05, 2007. Male patient was treated with ATACAND. After drug was administered, patient experienced the following problems/side effects: bradycardia, conduction disorder, hyperkalaemia, . ATACAND dosage: unknown. During the same period patient was treated with LASIX, SYMBICORT, ARANESP, TARDYFERON, IMOVANE, NITRODERM, LANTUS. Patient was hospitalized. Patient recovered.
CONDUCTION DISORDER : Morphine Side Effects Report #5522030-9
MORPHINE SULPHATE problem was reported by a Physician from UNITED STATES on Nov 06, 2007. Female patient, weighting 31.53 lb, was diagnosed with amnesia, analgesia, induction of anaesthesia and was treated with MORPHINE SULPHATE. After drug was administered, patient experienced the following problems/side effects: bradycardia, conduction disorder, electrocardiogram qrs complex prolonged, femoral pulse decreased, . MORPHINE SULPHATE dosage: 0.28 MG/H (20 MCG/KG/H), INTRAVENOUS. During the same period patient was treated with MORPHINE SULPHATE, VECURONIUM BROMIDE, VECURONIUM BROMIDE, THIOPENTAL, SUCCINYLCHOLINE CHLORIDE, MIDAZOLAM. Patient recovered.
CONDUCTION DISORDER : Atenolol Side Effects Report #5504998-X
Health Professional from UNITED STATES reported ATENOLOL problem on Oct 31, 2007. Female patient, 39 years of age, weighting 171.0 lb, was diagnosed with aortic valve replacement and was treated with ATENOLOL. After drug was administered, patient experienced the following problems/side effects: asthenia, conduction disorder, dizziness, feeling abnormal, female orgasmic disorder, hypoaesthesia, nervous system disorder, sleep disorder, thinking abnormal, . ATENOLOL dosage: unknown. Patient was hospitalized. Patient recovered.
CONDUCTION DISORDER : Morphine Side Effects Report #5418455-2
MORPHINE SULPHATE problem was reported by a Consumer or non-health professional from on Aug 16, 2007. Female patient, weighting 31.53 lb, was diagnosed with induction of anaesthesia, glycogen storage disease type ii, iron deficiency and was treated with MORPHINE SULPHATE. After drug was administered, patient experienced the following problems/side effects: bradycardia, conduction disorder, electrocardiogram qrs complex prolonged, . MORPHINE SULPHATE dosage: 0.28 MG/H. During the same period patient was treated with MIDAZOLAM, THIOPENTAL, SUCCINYLCHOLINE CHLORIDE, VECURONIUM BROMIDE, ALIMEMAZINE TARTRATE, TRICLOFOS, RECOMBINANT ACID ALPHA GLUCOSIDASE, FEREDETATE. Patient recovered.
CONDUCTION DISORDER : Fabrazyme Side Effects Report #5533872-8
Physician from JAPAN reported FABRAZYME problem on Nov 16, 2007. Male patient, 55 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, conduction disorder, disease progression, hepatic function abnormal, . FABRAZYME dosage: 50 MG Q2WKS IV. During the same period patient was treated with BETA BLOCKER. Patient died on 11/14/2007.
CONDUCTION DISORDER : Diclofenac Side Effects Report #5493263-5
DICLOFENAC problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 22, 2007. Female patient, 52 years of age, weighting 164.0 lb, was diagnosed with osteoarthritis and was treated with DICLOFENAC. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete, cardiac arrest, conduction disorder, gastrooesophageal reflux disease, . DICLOFENAC dosage: 75 MG 2 X DAILY. Patient was hospitalized. Patient recovered.
CONDUCTION DISORDER : Zelnorm Side Effects Report #5410823-8
Consumer or non-health professional from UNITED STATES reported ZELNORM problem on Aug 03, 2007. Female patient, 49 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELNORM. After drug was administered, patient experienced the following problems/side effects: anxiety, arrhythmia, conduction disorder, depressed mood, insomnia, irritable bowel syndrome, overdose, panic attack, restless legs syndrome, . ZELNORM dosage: 6 MG, BID. During the same period patient was treated with VICODIN, BUSPAR, EFFEXOR, PROTONIX, KLONOPIN, CENESTIN, ATIVAN. Patient was hospitalized. Patient recovered.
CONDUCTION DISORDER : Zelnorm Side Effects Report #5376823-1
ZELNORM problem was reported by a Consumer or non-health professional from UNITED STATES on June 27, 2007. Female patient, 49 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELNORM. After drug was administered, patient experienced the following problems/side effects: anxiety, arrhythmia, conduction disorder, depressed mood, insomnia, irritable bowel syndrome, overdose, panic attack, restless legs syndrome, . ZELNORM dosage: 6 MG, BID. During the same period patient was treated with VICODIN, BUSPAR, EFFEXOR, PROTONIX, KLONOPIN, CENESTIN, ATIVAN, MAGNESIUM SULPHATE. Patient was hospitalized. Patient recovered.
CONDUCTION DISORDER : Zelnorm Side Effects Report #5396207-X
Consumer or non-health professional from UNITED STATES reported ZELNORM problem on July 16, 2007. Female patient, 49 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELNORM. After drug was administered, patient experienced the following problems/side effects: anxiety, arrhythmia, conduction disorder, depressed mood, insomnia, irritable bowel syndrome, overdose, panic attack, restless legs syndrome, . ZELNORM dosage: 6 MG, BID. During the same period patient was treated with VICODIN, BUSPAR, EFFEXOR, PROTONIX, KLONOPIN, CENESTIN, ATIVAN, MAGNESIUM SULPHATE. Patient was hospitalized. Patient recovered.
CONDUCTION DISORDER : Zelnorm Side Effects Report #5399828-3
ZELNORM problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient, 49 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELNORM. After drug was administered, patient experienced the following problems/side effects: anxiety, arrhythmia, conduction disorder, depressed mood, insomnia, irritable bowel syndrome, overdose, panic attack, restless legs syndrome, . ZELNORM dosage: 6 MG, BID. During the same period patient was treated with VICODIN, BUSPAR, EFFEXOR, PROTONIX, KLONOPIN, CENESTIN, ATIVAN. Patient was hospitalized. Patient recovered.
CONDUCTION DISORDER : Zelnorm Side Effects Report #5376823-1
Consumer or non-health professional from UNITED STATES reported ZELNORM problem on June 27, 2007. Female patient, 49 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELNORM. After drug was administered, patient experienced the following problems/side effects: anxiety, arrhythmia, conduction disorder, depressed mood, insomnia, irritable bowel syndrome, overdose, panic attack, restless legs syndrome, . ZELNORM dosage: 6 MG, BID. During the same period patient was treated with VICODIN, BUSPAR, EFFEXOR, PROTONIX, KLONOPIN, CENESTIN, ATIVAN, MAGNESIUM SULPHATE. Patient was hospitalized. Patient recovered.
CONDUCTION DISORDER : Zelnorm Side Effects Report #5396207-X
ZELNORM problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient, 49 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELNORM. After drug was administered, patient experienced the following problems/side effects: anxiety, arrhythmia, conduction disorder, depressed mood, insomnia, irritable bowel syndrome, overdose, panic attack, restless legs syndrome, . ZELNORM dosage: 6 MG, BID. During the same period patient was treated with VICODIN, BUSPAR, EFFEXOR, PROTONIX, KLONOPIN, CENESTIN, ATIVAN, MAGNESIUM SULPHATE. Patient was hospitalized. Patient recovered.
CONDUCTION DISORDER : Zelnorm Side Effects Report #5399828-3
Consumer or non-health professional from UNITED STATES reported ZELNORM problem on July 16, 2007. Female patient, 49 years of age, was diagnosed with irritable bowel syndrome and was treated with ZELNORM. After drug was administered, patient experienced the following problems/side effects: anxiety, arrhythmia, conduction disorder, depressed mood, insomnia, irritable bowel syndrome, overdose, panic attack, restless legs syndrome, . ZELNORM dosage: 6 MG, BID. During the same period patient was treated with VICODIN, BUSPAR, EFFEXOR, PROTONIX, KLONOPIN, CENESTIN, ATIVAN. Patient was hospitalized. Patient recovered.